Tuberculosis News and Research

Latest Tuberculosis News and Research

McGill research team finds distinct disease-causing mutations and saves baby girl

About two years ago, Dr. Philippe Gros, a McGill University professor in the Department of Biochemistry and a Principal Investigator in thd McGill Life Sciences Complex, described a mouse mutant that was immunodeficient and hypersensitive to the Bacille Calmette-Gu-rin (BCG) vaccine and to tuberculosis (TB).

12 May 2011

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

James Collins, a pioneering researcher in the new field of systems biology and a MacArthur Genius, says: "You know the old saying: 'a spoonful of sugar makes the medicine go down?' This is more like 'a spoonful of sugar makes the medicine work.'

12 May 2011

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

UCB announced today results from a post hoc analysis of the RAPID 1 study published in the Journal of Rheumatology. The results suggest moderate to severe rheumatoid arthritis patients treated with Cimzia, the only approved PEGylated anti-TNF, together with methotrexate, achieved a rapid response associated with improved long-term outcomes one year after treatment began.

11 May 2011

GlobalPost examines Pres. Obama's Global Health Initiative

GlobalPost has published two articles on President Barack Obama's Global Health Initiative. "In a series of reports over the coming months from Washington and in capitals around the world, GlobalPost will examine the behind-the-scenes decisions in the Obama administration as well as what diplomats and health experts are doing now in several countries to try to bring to life this new, but what some say is a stumbling approach in global health," the publication writes.

11 May 2011

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Belgian physicians report they have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB) using a novel two-drug combination developed by researchers at Albert Einstein College of Medicine of Yeshiva University. The report, published in the Pediatric Infectious Disease Journal, marks the first known clinical use of this treatment for XDR-TB, the most deadly form of the disease.

11 May 2011

Uganda: First vaccination for GMZ2 malaria vaccine trial

Today, the EDCTP-funded GMZ2 consortium starts volunteer enrolment for the phase IIb clinical trial of the candidate malaria vaccine GMZ2 in Uganda. This is the third trial site to initiate volunteer recruitment for this multi-country study. Vaccination is already underway at trial sites in Gabon (November 2010) and Burkina Faso (April 2011). The Uganda site is in the peri-urban area of Iganga/Mayuge, at the Iganga Hospital. Akin to most areas in Uganda, malaria is one of the major health problems in this district. A team from Makerere University (Kampala) is conducting the trial.

9 May 2011

World's first urine-based tuberculosis diagnostics tool

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostics systems and technology for HIV, hepatitis, tuberculosis, cholera and malaria detection, and other innovative technologies, in a new video today unveiled the world's first urine-based tuberculosis diagnostics tool.

9 May 2011

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

Democrats may be feeling smug about their campaign against the House Republican budget plan, and as a matter of politics, they're no doubt right. If the goal is to deal with the long-term fiscal challenge, though, the Democrats' political success is apt only to prolong the gridlock and make the eventual solution that much more painful. ...

9 May 2011

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Cempra Pharmaceuticals, a developer of differentiated antibiotics, today announced an oral presentation showing that intravenous (IV) solithromycin demonstrates excellent tolerability and a favorable pharmacokinetic profile at IV doses up to 800 mg.

7 May 2011

Filipino children with KD at greater risk for inflammation of heart blood vessels

While children of all ethnicities can contract Kawasaki disease (KD), a study led by researchers at the Kawasaki Disease Research Center at the University of California, San Diego and Rady Children's Hospital-San Diego finds that Filipino children with KD are at a higher risk for inflammation of the blood vessels of the heart than those of other Asian and non-Asian backgrounds.

7 May 2011

TB medication variations in private markets could harm treatment efforts, study says

A wide variation in the dosages and forms of medicines prescribed by private physicians to patients with tuberculosis in developing countries could lead to the development of more drug-resistant strains of the bacterial infection, according to a study published online Wednesday in PLoS One, the Financial Times reports.

6 May 2011

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

When Mother's Day is recognized on Sunday, "let's honor motherhood itself by giving all moms the gift they want most - the chance to deliver and raise healthy children," former Sens. Bill Frist and Jon Corzine, who serve as co-chairs of the Save the Children's Newborn and Child Survival Campaign, write in The Hill's "Congress Blog."

6 May 2011

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration approved Afinitor tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin in patients with unresectable, locally advanced or metastatic disease.

6 May 2011

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

Tulsa Shock guard Andrea Riley and Basketball Hall of Famer Bob Lanier teamed up with NBA Cares and the Society for Adolescent Health and Medicine today to bring Vaccines for Teens to the Tulsa community.

5 May 2011

SBS explores ‘superbugs’ on Insight Tuesday 10th May

Since the discovery of penicillin in the early twentieth century, antibiotics have fought infections and diseases that were once life threatening. But over time, many bacteria have become resistant to these drugs and patients are increasingly at risk.

3 May 2011

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company today announced that the U.S. Food and Drug Administration approved Tradjenta tablets, a prescription medication used along with diet and exercise to lower blood sugar in adults with type 2 diabetes.

3 May 2011

Regulatory Science Consortium adds 10 new member organizations

Critical Path Institute is proud to announce that the Regulatory Science Consortium, an arm of the Critical Path to TB Drug Regimens, has added 10 new member organizations that include over 100 participants in five workgroups.

30 Apr 2011

Preventive measures needed to ensure protection from workplace hazards, ILO head says

Preventive measures are the best way to ensure people are protected from hazards in the workplace, U.N. International Labor Union Director-General Juan Somavia said in a message Thursday marking the World Day for Safety and Health at Work, the U.N. News Centre reports.

30 Apr 2011

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

Libya will run out of food within two months unless efforts are stepped up to get shipments into the war-torn country, the World Food Program warned on Thursday, Deustche Presse-Agentur/M&C reports.

30 Apr 2011

New genetic study suspects Armadillos as source of leprosy in the U.S.

A new genetic study on leprosy bacteria reports that armadillos may be a source of infection in the Southern United States.

29 Apr 2011

Tuberculosis News and Research

Latest Tuberculosis News and Research

McGill research team finds distinct disease-causing mutations and saves baby girl

Sugar boosts effectiveness of first-line antibiotics against chronic bacterial infections

Journal of Rheumatology publishes positive results from Cimzia Phase III trial in RA

GlobalPost examines Pres. Obama's Global Health Initiative

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Uganda: First vaccination for GMZ2 malaria vaccine trial

World's first urine-based tuberculosis diagnostics tool

Viewpoints: Dems' Medicare strategy; Health disparities; Chicago hospital dispute

Cempra to present solithromycin Phase 1 study data at ECCMID/ICC meeting

Filipino children with KD at greater risk for inflammation of heart blood vessels

TB medication variations in private markets could harm treatment efforts, study says

Opinions: U.S. support for maternal, child health; infection control at borders; the AMFm model; International Affairs budget; organizations supporting women

FDA approves Novartis' Afinitor tablets for pancreatic NET treatment

NBA Cares, SAHM and Tulsa Shock guard partner for teen vaccine awareness campaign

SBS explores ‘superbugs’ on Insight Tuesday 10th May

Boehringer Ingelheim, Eli Lilly receive FDA approval for Tradjenta to treat type 2 diabetes

Regulatory Science Consortium adds 10 new member organizations

Preventive measures needed to ensure protection from workplace hazards, ILO head says

Also in global health news: Libya food shortage; PMTCT in Swaziland; TB detection in U.K.; food issues in Foreign Policy magazine

New genetic study suspects Armadillos as source of leprosy in the U.S.

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in